Fendigo SA becomes wholly owned subsidiary of Sequent Scientific Limited

Consequent to acquisition of 7.5% stake from Mr. Bernard Bradfer in Fendigo SA through Alivira Animal Health Limited, Ireland, Wholly Owned Subsidiary of Sequent Scientific Limited.

The consideration paid for the acquisition is Euro 551075 (Five Hundred and Fifty-One Thousand Seventy-Five euro).

Consequent to the above acquisition, Fendigo SA has become a Wholly Owned Subsidiary of the Company.

Fendigo is a veterinary pharmaceutical Company operating in the Benelux region. The Company is involved in sales and marketing of veterinary and health products for pets, farm animals, Horses, and poultry. By a wide portfolio of products Fendigo responds to the actual needs of veterinarians, farmers, and other parties of the Animal Health Sector.

Shares of SEQUENT SCIENTIFIC LTD. was last trading in BSE at Rs.240 as compared to the previous close of Rs. 240.5. The total number of shares traded during the day was 15659 in over 649 trades.

The stock hit an intraday high of Rs. 243.7 and intraday low of 235. The net turnover during the day was Rs. 3761378.

Source : Equity Bulls

Keywords